CAS No.:33069-62-4
Name: Paclitaxel
Details Introduction
TOXICITY DATA with REFERENCE:
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| dog | LDLo | intravenous | 15mg/kg (15mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: RESPIRATORY STIMULATION |
National Technical Information Service. Vol. PB83-170969, |
| mouse | LD50 | intraperitoneal | 128mg/kg (128mg/kg) | SKIN AND APPENDAGES (SKIN): HAIR: OTHER | National Technical Information Service. Vol. PB83-170969, |
| mouse | LD50 | intravenous | 12mg/kg (12mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) BEHAVIORAL: ATAXIA LUNGS, THORAX, OR RESPIRATION: RESPIRATORY DEPRESSION |
Pharmaceutical Research. Vol. 4, Pg. 162, 1987. |
| rat | LD50 | intraperitoneal | 32530ug/kg (32.53mg/kg) | BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) LUNGS, THORAX, OR RESPIRATION: DYSPNEA |
National Technical Information Service. Vol. PB83-170969, |
| rat | LDLo | intravenous | 85mg/kg (85mg/kg) | LUNGS, THORAX, OR RESPIRATION: OTHER CHANGES BLOOD: CHANGES IN BONE MARROW NOT INCLUDED ABOVE |
Journal of Toxicological Sciences. Vol. 19(Suppl, |
| women | LDLo | intravenous | 4995mg/kg/3H- (4995mg/kg) | CARDIAC: CARDIOMYOPATHY INCLUDING INFARCTION BLOOD: LEUKOPENIA BLOOD: THROMBOCYTOPENIA |
Lancet. Vol. 343, Pg. 727, 1994. |
Consensus Reports:
SAFETY PROFILE:
Safety Information about Paclitaxel (CAS NO.33069-62-4):
Hazard Codes:
Xn
Risk Statements: 37/38-41-42/43-62-68-40-48-20/21/22
R20/21/22: Harmful by inhalation, in contact with skin and if swallowed.
R37/38: Irritating to respiratory system and skin.
R40: Limited evidence of a carcinogenic effect.
R41: Risk of serious damage to the eyes.
R42/43: May cause sensitization by inhalation and skin contact.
R48: Danger of serious damage to health by prolonged exposure.
R62: Risk of impaired fertility.
R68: Possible risk of irreversible effects.
Safety Statements: 22-26-36/37/39-45
S22: Do not breathe dust.
S26: In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.
S36/37/39: Wear suitable protective clothing, gloves and eye/face protection.
S45: In case of accident or if you feel unwell, seek medical advice immediately (show the label whenever possible.)
RIDADR: 1544
WGK Germany: 3
RTECS: DA8340700
F: 10-21
HazardClass: 6.1(b)
PackingGroup: III
Standards and Recommendations:
Analytical Methods:
Related Searches
Related Suppliers
- Shanghai FWD Chemicals ltd
- VESINO INDUSTRIAL CO., LTD.
- MedKoo Biosciences, Inc
- Melone Pharmaceutical Co., ltd
- LianYunGang Henrychem Science Co.,Ltd.
- SPE Chemicals Co.,Ltd
- Venus Chemicals
- Shanghai Forever Biotech Co., Ltd.
- Xenos Bioresources
- HANGZHOU ICH BIOFARM CO.,LTD
- Shilpa Medicare Ltd
- Changsha Nutramax Inc
- PRAEVIDEO LLC
- Jiangsu Chiatai Qingjiang Pharmaceutical Co.,Ltd
- Hindchem Corporation
- Shanghai Forever Synthesis Co.,Ltd.
- Beijing Zhongshuo Pharmaceutical T & D Co.,Ltd
- Watson International Ltd
- Zhejiang Chemline International Co., Ltd.
- Jinan Great Chemical Co.,Ltd.
Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione


